A Hepatitis C Virus-Associated Chronic Hepatitis Patient Developing Various Adverse Events Including Severe Gingivitis, Gingival Bleeding, and Inflammation of Genital Vulva during the Course of Antiviral Therapy with Elbasvir/Grazoprevir

Oral direct-acting antivirals comprise the main therapy for hepatitis C virus (HCV)-associated liver disease in Japan. Daclatasvir/asunaprevir is the primary agent and sofosbuvir/ledipasvir is the secondary agent for HCV genotype 1b. Ombitasvir/paritaprevir/ritonavir was also recommended as a therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarao, Kazuo, Sato, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803708/
https://www.ncbi.nlm.nih.gov/pubmed/29430226
http://dx.doi.org/10.1159/000484135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803708/
https://www.ncbi.nlm.nih.gov/pubmed/29430226
http://dx.doi.org/10.1159/000484135

Ejemplares similares